LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aandelen Lijst・NeoGenomics Inc

NeoGenomics Inc

Gesloten

9.23 1.54

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.19

Max

9.25

Belangrijke statistieken
By Trading Economics
Inkomsten	-7.2M -17M
Verkoop	-3.5M 187M
EPS	0.01
Winstmarge	-9.164
Werknemers	2,500
EBITDA	-5.8M -567K

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+61.76% upside

Dividenden
By Dow Jones
Volgende Winsten	28 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-31M 1.1B
Vorige openingsprijs	7.69
Vorige sluitingsprijs	9.23

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mei 2026, 18:09 UTC

Marktinformatie

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mei 2026, 16:54 UTC

Marktinformatie

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mei 2026, 14:53 UTC

Marktinformatie

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 mei 2026, 11:51 UTC

Marktinformatie

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 mei 2026, 07:28 UTC

Marktinformatie

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21 mei 2026, 17:04 UTC

Marktinformatie

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 mei 2026, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

21 mei 2026, 16:08 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

21 mei 2026, 16:08 UTC

Marktinformatie

Zcash Backtracks After Yesterday's Surge -- Market Talk

21 mei 2026, 15:39 UTC

Marktinformatie

Global Equities Roundup: Market Talk

21 mei 2026, 15:39 UTC

Marktinformatie

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21 mei 2026, 13:52 UTC

Marktinformatie

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21 mei 2026, 07:03 UTC

Marktinformatie

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20 mei 2026, 17:08 UTC

Marktinformatie

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 mei 2026, 16:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

20 mei 2026, 15:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

20 mei 2026, 15:51 UTC

Marktinformatie

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 mei 2026, 15:39 UTC

Marktinformatie

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 mei 2026, 13:08 UTC

Marktinformatie

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 mei 2026, 12:44 UTC

Marktinformatie

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 mei 2026, 07:25 UTC

Marktinformatie

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 mei 2026, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

19 mei 2026, 15:54 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

19 mei 2026, 15:54 UTC

Marktinformatie

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 mei 2026, 14:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

19 mei 2026, 14:51 UTC

Marktinformatie

Ethereum Down From Near-Term High -- Market Talk

19 mei 2026, 08:26 UTC

Marktinformatie

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 mei 2026, 08:26 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

18 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

18 mei 2026, 17:22 UTC

Marktinformatie

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

61.76% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14.93 USD 61.76%

Hoogste 25 USD

Laagste 11 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Gebaseerd op 10 analisten die aandelenratings hebben gegeven aan NeoGenomics Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.